Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study.
Al Sulaiman K, Aljuhani O, Korayem GB, Hafiz A, Alalawi M, Badreldin HA, Altebainawi AF, Vishwakarma R, Alissa A, Alghamdi A, Alenazi AA, Al Enazi H, Alanazi S, Alhammad A, Alghamdi J, AlFaifi M, Al Sehli FA, Aldossari MA, Alhubaishi AA, Al-Ali AY, Al-Dorzi HM. Al Sulaiman K, et al. Among authors: alfaifi m. Thromb J. 2022 Dec 8;20(1):74. doi: 10.1186/s12959-022-00432-9. Thromb J. 2022. PMID: 36482388 Free PMC article.
Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study - New-Onset Atrial Fibrillation and COVID-19.
Kensara R, Aljuhani O, Korayem GB, Alkofide H, Almohareb SN, Alosaimi YS, Altebainawi AF, Bin Saleh K, Andas NA, Harbi SA, Harthi AFA, Ashkan U, Alghamdi R, Badreldin HA, Hafiz A, AlFaifi M, Alqahtani RA, Vishwakarma R, Alenazi AA, Alalawi M, Mahboob R, Alfouzan RA, Al Tuhayni LB, Qahtani NA, Sulaiman KA. Kensara R, et al. Among authors: alfaifi m. Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231156178. doi: 10.1177/10760296231156178. Clin Appl Thromb Hemost. 2023. PMID: 36789786 Free PMC article.
The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study.
Aljuhani O, Korayem GB, Altebainawi AF, Alotaibi MS, Alrakban NA, Ghoneim RH, Vishwakarma R, Al Shaya AI, Al Harbi S, Gramish J, Almutairi DM, Alqannam G, Alamri FF, Alharthi AF, Alfaifi M, Al Amer A, Alenazi AA, Bin Aydan N, Alalawi M, Al Sulaiman K. Aljuhani O, et al. Among authors: alfaifi m. Saudi Pharm J. 2023 Jul;31(7):1210-1218. doi: 10.1016/j.jsps.2023.05.006. Epub 2023 May 23. Saudi Pharm J. 2023. PMID: 37256102 Free PMC article.
Doxycycline's Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study.
Al Sulaiman K, Aljuhani O, Korayem GB, Alnajjar LI, Altebainawi AF, AlFaifi M, Vishwakarma R, Alenazi AA, Alalawi M, Alissa A, Alsowaida YS, Alsohimi S, Almagthali A, Alay SM, Altaher N, Alamri MG, Alangari D, Alzahrani A, Abdul Razack HI, Alhamoud J, Alshaya A, Gramish J, Al Aamer K, Alsaeedi AS, Alghamdi G. Al Sulaiman K, et al. Among authors: alfaifi m. Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231177017. doi: 10.1177/10760296231177017. Clin Appl Thromb Hemost. 2023. PMID: 37322869 Free PMC article.
When antivirals backfire: An evaluation of favipiravir's clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study.
Al Sulaiman K, Aljuhani O, Korayem GB, Altebainawi AF, AlFaifi M, Nahari M, Almagthali A, Thabit AK, Alhajaji R, Alharbi R, Kahtani K, Alenazi AA, Alharbi A, Alghwainm MM, Alotaibi SM, Alghamdi YS, Alotaibi S, Alonazi SH, Almutairi JM, Vishwakarma R. Al Sulaiman K, et al. Among authors: alfaifi m. J Infect Public Health. 2023 Sep;16(9):1492-1499. doi: 10.1016/j.jiph.2023.06.011. Epub 2023 Jun 14. J Infect Public Health. 2023. PMID: 37355406 Free PMC article.
Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review and Meta-Analysis.
Hafiz A, Alkofide H, Al Sulaiman K, Joharji H, Aljohani S, Sarkhi KA, Alharbi R, Korayem GB, AlFaifi M, Alsohimi S, Aljuhani O. Hafiz A, et al. Among authors: alfaifi m. Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231191123. doi: 10.1177/10760296231191123. Clin Appl Thromb Hemost. 2023. PMID: 37547931 Free PMC article.
Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study.
Al Sulaiman K, Aljuhani O, Korayem GB, Altebainawi A, Alharbi R, Assadoon M, Vishwakarma R, Ismail NH, Alshehri AA, Al Mutairi FE, AlFaifi M, Alharthi AF, Alenazi AA, Alalawi M, Al Zumai O, Al Haji H, Al Dughaish ST, Alawaji AS, Alhaidal HA, Al Ghamdi G. Al Sulaiman K, et al. Among authors: alfaifi m. BMC Pulm Med. 2023 Aug 28;23(1):315. doi: 10.1186/s12890-023-02603-4. BMC Pulm Med. 2023. PMID: 37641042 Free PMC article.
Correction: Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study.
Al Sulaiman K, Aljuhani O, Korayem GB, Altebainawi AF, Alharbi R, Assadoon M, Vishwakarma R, Ismail NH, Alshehri AA, Al Mutairi FE, AlFaifi M, Alharthi AF, Alenazi AA, Alalawi M, Al Zumai O, Al Haji H, Al Dughaish ST, Alawaji AS, Alhaidal HA, Al Ghamdi G. Al Sulaiman K, et al. Among authors: alfaifi m. BMC Pulm Med. 2023 Oct 17;23(1):392. doi: 10.1186/s12890-023-02687-y. BMC Pulm Med. 2023. PMID: 37848847 Free PMC article. No abstract available.
The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study.
Aljuhani O, Al Sulaiman K, B Korayem G, Alharbi A, Altebainawi AF, Aldkheel SA, Alotaibi SG, Vishwakarma R, Alshareef H, Alsohimi S, AlFaifi M, Al Shaya A, Alhaidal HA, Alsubaie RM, Alrashidi H, Albarqi KJ, Alangari DT, Alanazi RM, Altaher NM, Al-Dorzi HM. Aljuhani O, et al. Among authors: alfaifi m. Ren Fail. 2023;45(2):2268213. doi: 10.1080/0886022X.2023.2268213. Epub 2023 Oct 23. Ren Fail. 2023. PMID: 37870869 Free PMC article.
224 results